StockMacro
Menu

LeMaitre Vascular

$73.61 -25% in 6 monthsMarket cap $1.7B

LMAT on XNAS, Health Care, LeMaitre Vascular, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue rose 11% but shares fell 25% in six months while short interest rose to 1.5 times last year.

  • BadInstitutional holders fell to 296 from 319 last quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
655
Website
lemaitre.com
Listed
Nasdaq, US
Last results
4 Nov 2026
Next results
expected around 24 Feb 2027 (an estimate: a year ago it reported on 25 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $68.0M, net income $15.0M.
Quarter to 31 Dec 2021: revenue $39.5M, net income $6.2MQuarter to 31 Dec 2021: revenue $39.5M, net income $6.2MQuarter to 31 Mar 2022: revenue $39.6M, net income $6.0MQuarter to 31 Mar 2022: revenue $39.6M, net income $6.0MQuarter to 30 Jun 2022: revenue $42.1M, net income $3.5MQuarter to 30 Jun 2022: revenue $42.1M, net income $3.5MQuarter to 30 Sep 2022: revenue $39.0M, net income $5.5MQuarter to 30 Sep 2022: revenue $39.0M, net income $5.5MQuarter to 31 Dec 2022: revenue $41.0M, net income $5.6MQuarter to 31 Dec 2022: revenue $41.0M, net income $5.6MQuarter to 31 Mar 2023: revenue $47.1M, net income $6.0MQuarter to 31 Mar 2023: revenue $47.1M, net income $6.0MQuarter to 30 Jun 2023: revenue $50.1M, net income $8.1MQuarter to 30 Jun 2023: revenue $50.1M, net income $8.1MQuarter to 30 Sep 2023: revenue $47.4M, net income $7.5MQuarter to 30 Sep 2023: revenue $47.4M, net income $7.5MQuarter to 31 Dec 2023: revenue $48.9M, net income $8.5MQuarter to 31 Dec 2023: revenue $48.9M, net income $8.5MQuarter to 31 Mar 2024: revenue $53.5M, net income $9.9MQuarter to 31 Mar 2024: revenue $53.5M, net income $9.9MQuarter to 30 Jun 2024: revenue $55.8M, net income $11.8MQuarter to 30 Jun 2024: revenue $55.8M, net income $11.8MQuarter to 30 Sep 2024: revenue $54.8M, net income $11.1MQuarter to 30 Sep 2024: revenue $54.8M, net income $11.1MQuarter to 31 Dec 2024: revenue $55.7M, net income $11.2MQuarter to 31 Dec 2024: revenue $55.7M, net income $11.2MQuarter to 31 Mar 2025: revenue $59.9M, net income $11.0MQuarter to 31 Mar 2025: revenue $59.9M, net income $11.0MQuarter to 30 Jun 2025: revenue $64.2M, net income $13.8MQuarter to 30 Jun 2025: revenue $64.2M, net income $13.8MQuarter to 30 Sep 2025: revenue $61.0M, net income $17.4MQuarter to 30 Sep 2025: revenue $61.0M, net income $17.4MQuarter to 31 Dec 2025: revenue –, net income $15.6MQuarter to 31 Mar 2026: revenue $66.6M, net income $15.7MQuarter to 31 Mar 2026: revenue $66.6M, net income $15.7MQuarter to 30 Jun 2026: revenue $70.4M, net income $17.1MQuarter to 30 Jun 2026: revenue $70.4M, net income $17.1MQuarter to 30 Sep 2026: revenue $68.0M, net income $15.0MQuarter to 30 Sep 2026: revenue $68.0M, net income $15.0M
31 Dec 2021RevenueNet incometallest bar $70.4M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$68.0M$15.0M
30 Jun 2026$70.4M$17.1M
31 Mar 2026$66.6M$15.7M
31 Dec 2025–$15.6M
30 Sep 2025$61.0M$17.4M
30 Jun 2025$64.2M$13.8M
31 Mar 2025$59.9M$11.0M
31 Dec 2024$55.7M$11.2M
30 Sep 2024$54.8M$11.1M
30 Jun 2024$55.8M$11.8M
31 Mar 2024$53.5M$9.9M
31 Dec 2023$48.9M$8.5M
30 Sep 2023$47.4M$7.5M
30 Jun 2023$50.1M$8.1M
31 Mar 2023$47.1M$6.0M
31 Dec 2022$41.0M$5.6M
30 Sep 2022$39.0M$5.5M
30 Jun 2022$42.1M$3.5M
31 Mar 2022$39.6M$6.0M
31 Dec 2021$39.5M$6.2M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $269.4M $240.9M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +12% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $63.3M $53.3M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $2.75 $2.31
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 72.0% 71.0% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 27.7% 25.7% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 23.5% 22.1% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 15.6% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $67.0M $66.2M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $389.7M $343.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $169.3M $168.4M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$220.4M (net cash) -$174.6M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.39 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $18.89
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 26.6 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 6.3 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 5.4 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.9 2.8
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 1.1% 1.4%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
LeMaitre VascularLMAT (this company) $1.7B26.66.3+12%23.5%
Inspire Medical SystemsINSP $1.6B15.81.8-0.2%11.4%
Kestra Medical TechnologiesKMTS $1.5Bloss14.0+61%-140%
PROCEPT BioRoboticsPRCT $1.4Bloss4.0+17%-32.6%
UFP TechnologiesUFPT $2.3B29.43.5+8.6%11.8%
NovoCureNVCR $1.3Bloss1.7+13%-16.8%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-7.2%

296 13F filers vs 319

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

23.9M shares held by 13F filers (30 Sep 2026) of 22.9M outstanding (2 Nov 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

7.2%

1.7M shares sold short (30 Oct 2026) of 22.9M outstanding (2 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

6.2

1.7M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-6.7%

1.8M shares sold short in the report before, 1.7M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

45%

45% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 65%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

21

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+11%

$68.0M vs $61.0M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+2.3%

$2.3M vs $2.3M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$202K

the 12 months before: $214K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

17

17 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

17×

17 articles in the last 7 days; its usual week has 1.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 1.8M, 1.5× a year earlier

Price $73.61 on 20 Nov 2026, -13% over 12 months (12-month range $73.61 to $117.39)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $30.0M in the last 12 months (the 12 months before: -$21.1M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 0 published in the last 12 months.
Revenue per quarter. Revenue $68.0M in the latest quarter, +11% on a year earlier.
Capital spending per quarter. Capital spending $2.3M in the latest quarter, +2.3% on a year earlier.
Institutional holders (13F filers). 296 13F filers reported holding it in the latest 13F quarter, +5.0% on a year earlier.
Federal obligations. Federal obligations: $56K published in the last 12 months, -81% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
27 Oct 2026Sharp changeShort interest spike: short interest spike, 1.8M vs usual 1.2M (2026-10-15); 1.5x the same period a year earlier
15 Oct 20268-K and other filingsDirector or officer change
15 Oct 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 Oct 2026Sharp changeShort interest spike: short interest spike, 1.7M vs usual 1.2M (2026-09-30); 1.4x the same period a year earlier
29 Sep 2026Sharp changeShort interest spike: short interest spike, 1.7M vs usual 1.2M (2026-09-15); 1.3x the same period a year earlier
14 Apr 20268-K and other filingsDirector or officer change
14 Apr 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Nov 2025Sharp changeMany funds opening a new position: many funds opening a new position, 37 vs usual 24 (2025-09-30); 1.0x the same period a year earlier
18 Feb 2025Sharp changeShort interest spike: short interest spike, 1.3M vs usual 854K (2025-01-31); 1.4x the same period a year earlier
13 Feb 20258-K and other filingsDirector or officer change
13 Feb 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Jan 2025Sharp changeShort interest spike: short interest spike, 1.3M vs usual 854K (2025-01-15); 1.3x the same period a year earlier
26 Aug 20248-K and other filingsDirector or officer change
3 Jun 20248-K and other filingsDirector or officer change
3 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 May 2024Sharp changeMany funds opening a new position: many funds opening a new position, 35 vs usual 21.50 (2024-03-31); 2.7x the same period a year earlier
13 Feb 2024Sharp changeShort interest spike: short interest spike, 920K vs usual 612K (2024-01-31); 2.0x the same period a year earlier
30 Jan 2024Sharp changeShort interest spike: short interest spike, 971K vs usual 609K (2024-01-12); 1.8x the same period a year earlier
16 Jan 2024Sharp changeShort interest spike: short interest spike, 961K vs usual 608K (2023-12-29); 1.7x the same period a year earlier
2 Jan 2024Sharp changeShort interest spike: short interest spike, 949K vs usual 608K (2023-12-15); 1.7x the same period a year earlier
12 Dec 2023Sharp changeShort interest spike: short interest spike, 952K vs usual 600K (2023-11-30); 1.7x the same period a year earlier
28 Nov 2023Sharp changeShort interest spike: short interest spike, 1.1M vs usual 587K (2023-11-15); 1.9x the same period a year earlier
14 Nov 2023Sharp changeShort interest spike: short interest spike, 1.2M vs usual 587K (2023-10-31); 1.5x the same period a year earlier
31 Oct 2023Sharp changeShort interest spike: short interest spike, 932K vs usual 587K (2023-10-13); 1.1x the same period a year earlier
15 Aug 2023Sharp changeMany funds opening a new position: many funds opening a new position, 41 vs usual 21 (2023-06-30); 2.0x the same period a year earlier
23 Sep 20228-K and other filingsDirector or officer change
23 Sep 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Apr 20228-K and other filingsRestructuring costs announced
2 Dec 20218-K and other filingsA major agreement ended
Insider net buying (open market)
Month from 1 Dec 2021: -$42K published
Month from 1 Mar 2022: -$378K published
Month from 1 Aug 2022: -$6.6M published
Month from 1 Dec 2022: -$821K published
Month from 1 Mar 2023: -$1.4M published
Month from 1 May 2023: -$11.0M published
Month from 1 Jun 2023: -$321K published
Month from 1 Dec 2023: -$4.0M published
Month from 1 Mar 2024: -$10.7M published
Month from 1 May 2024: -$16.0M published
Month from 1 Jul 2024: -$8.4M published
Month from 1 Aug 2024: -$266K published
Month from 1 Nov 2024: -$553K published
Month from 1 Mar 2025: -$814K published
Month from 1 May 2025: -$8.9M published
Month from 1 Aug 2025: -$11.4M published
Month from 1 Mar 2026: -$23.7M published
Month from 1 May 2026: -$6.3M published
H-1B/E-3 applications certified
Quarter from 1 Oct 2022: 1 published
Quarter from 1 Jan 2023: 1 published
Quarter from 1 Oct 2023: 2 published
Quarter from 1 Jan 2024: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $39.5M, +5.2% on a year earlier; public on 1 Mar 2022
Quarter ended 31 Mar 2022: $39.6M, +10% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $42.1M, +3.5% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $39.0M, +1.7% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $41.0M, +3.7% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $47.1M, +19% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $50.1M, +19% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $47.4M, +21% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $48.9M, +19% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $53.5M, +14% on a year earlier; public on 11 May 2024
Quarter ended 30 Jun 2024: $55.8M, +11% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $54.8M, +16% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $55.7M, +14% on a year earlier; public on 1 Mar 2025
Quarter ended 31 Mar 2025: $59.9M, +12% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $64.2M, +15% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $61.0M, +11% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Mar 2026: $66.6M, +11% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $70.4M, +9.6% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $68.0M, +11% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $606K, -50% on a year earlier; public on 1 Mar 2022
Quarter ended 31 Mar 2022: $536K, -49% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $973K, -31% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $460K, -75% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $1.3M, +108% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $2.1M, +297% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $2.8M, +188% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $1.1M, +129% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $1.3M, +1.5% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $1.4M, -36% on a year earlier; public on 11 May 2024
Quarter ended 30 Jun 2024: $1.9M, -33% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $1.7M, +59% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $2.0M, +60% on a year earlier; public on 1 Mar 2025
Quarter ended 31 Mar 2025: $1.4M, +0.9% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $1.3M, -29% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $2.3M, +37% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $1.8M, -13% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $2.8M, +101% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $2.3M, +72% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $2.3M, +2.3% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 166; public on 14 Feb 2022
31 Mar 2022 report: 172; public on 16 May 2022
30 Jun 2022 report: 172; public on 15 Aug 2022
30 Sep 2022 report: 173; public on 14 Nov 2022
31 Dec 2022 report: 169; public on 14 Feb 2023
31 Mar 2023 report: 176; public on 15 May 2023
30 Jun 2023 report: 199; public on 14 Aug 2023
30 Sep 2023 report: 205; public on 14 Nov 2023
31 Dec 2023 report: 216; public on 14 Feb 2024
31 Mar 2024 report: 237; public on 15 May 2024
30 Jun 2024 report: 247; public on 14 Aug 2024
30 Sep 2024 report: 276; public on 14 Nov 2024
31 Dec 2024 report: 300; public on 14 Feb 2025
31 Mar 2025 report: 279; public on 15 May 2025
30 Jun 2025 report: 271; public on 14 Aug 2025
30 Sep 2025 report: 282; public on 14 Nov 2025
31 Dec 2025 report: 289; public on 17 Feb 2026
31 Mar 2026 report: 332; public on 15 May 2026
30 Jun 2026 report: 319; public on 14 Aug 2026
30 Sep 2026 report: 296; public on 16 Nov 2026
Federal obligations
Month from 1 Dec 2021: $14K published
Month from 1 Jan 2022: $11K published
Month from 1 Apr 2022: $12K published
Month from 1 May 2022: -$2K published
Month from 1 Jun 2022: $43K published
Month from 1 Jul 2022: $23K published
Month from 1 Nov 2022: $13K published
Month from 1 Dec 2022: $12K published
Month from 1 Feb 2023: $24K published
Month from 1 Mar 2023: $28K published
Month from 1 Apr 2023: $53K published
Month from 1 May 2023: $0 published
Month from 1 Jun 2023: $25K published
Month from 1 Jul 2023: $24K published
Month from 1 Aug 2023: $28K published
Month from 1 Sep 2023: $11K published
Month from 1 Oct 2023: $56K published
Month from 1 Nov 2023: $13K published
Month from 1 Dec 2023: $27K published
Month from 1 Jan 2024: $45K published
Month from 1 Feb 2024: $32K published
Month from 1 May 2024: $133K published
Month from 1 Jun 2024: $37K published
Month from 1 Jul 2024: $11K published
Month from 1 Aug 2024: $22K published
Month from 1 Sep 2024: $27K published
Month from 1 Oct 2024: $11K published
Month from 1 Dec 2024: $14K published
Month from 1 Feb 2025: $27K published
Month from 1 Mar 2025: -$23K published
Month from 1 Apr 2025: $97K published
Month from 1 Jun 2025: $27K published
Month from 1 Jul 2025: $134 published
Month from 1 Aug 2025: $46K published
Month from 1 Sep 2025: $34K published
Month from 1 Oct 2025: $56K published
Month from 1 Nov 2025: $12K published
Month from 1 Mar 2026: $38K published
Month from 1 May 2026: $16K published
Month from 1 Jun 2026: $600 published
Month from 1 Aug 2026: $600 published
Month from 1 Nov 2026: $705 published

What is unusual now

  • Made public in the last 90 days: it had 1.8M shares sold short in the 15 Oct 2026 report, 1.5× the same report last year; it also had 1.7M shares sold short in the 30 Sep 2026 report, 1.4× the same report last year. 3 sharp changes in all.
  • Short interest spike: had 1.8M shares sold short in the 15 Oct 2026 report, 1.5× the same report last year Public on 27 Oct 2026.
  • Insider net buying (open market): Insiders sold a net $30.0M in the last 12 months (the 12 months before: -$21.1M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 0 published in the last 12 months.

Latest records

The names and amounts behind the totals, newest first

No trades in the last 90 days; the latest was filed 11 May 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
11 May 2026Bridget A RossDirectorSellafter exercising options5,044$111.10$560KForm 4
11 May 2026George W LeMaitreChairman and CEOSell46,481$108.27$5.0MForm 4
11 May 2026Lawrence J JasinskiDirectorSellafter exercising options3,943$110.00$434KForm 4
11 May 2026Trent G KamkeSenior V. P., OperationsSell2,928$107.00$313KForm 4
13 Mar 2026Trent G KamkeSenior V. P., OperationsSellafter exercising options2,625$108.50$285KForm 4
13 Mar 2026David B RobertsPresident and DirectorSell3,312$107.68$357KForm 4
2 Mar 2026Trent G KamkeSenior V. P., OperationsSellafter exercising options1,044$110.29$115KForm 4
2 Mar 2026George W LeMaitreChairman and CEOSellplanned in advance (10b5-1); after exercising options205,930$107.05$22.0MForm 4

296 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 32 opened a position, 60 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.3.3M14.6%$276.3M+72K+2.2%
First Trust Advisors LP1.1M4.96%$93.8M+42K+3.9%
T. Rowe Price Associates Inc979K4.28%+224K+30%
Congress Asset Management Co962K4.20%$79.4M-2,192-0.2%
Vanguard Capital Management LLC960K4.19%$79.2M+6,092+0.6%
Copeland Capital Management, LLC924K4.04%$76.3M+85K+10%
State Street Corp908K3.97%$75.0M+6,940+0.8%
Conestoga Capital Advisors, LLC879K3.84%$72.6M-489K-36%
Geode Capital Management, LLC737K3.22%$60.9M-52K-6.6%
Vanguard Portfolio Management LLC613K2.68%$50.6M+7,725+1.3%

Company events

All 29 company events

In 12 months: 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
15 Oct 2026Director or officer change8-K
14 Apr 2026Director or officer change8-K
13 Feb 2025Director or officer change8-K
19 Dec 2024Signed a major agreementSame filing: took on new debt, sold shares privately8-K
26 Aug 2024Director or officer change8-K
3 Jun 2024Director or officer changeSame filing: shareholder vote results8-K
1 Nov 2023Signed a major agreement8-K
23 Sep 2022Director or officer change8-K

21 open postings; careers site tracked since 21 Nov 2026. Most in Sales & business development 48%, Finance & accounting 24%, Software engineering 14%, Test, quality & reliability 10%.

PostedJobLocation
21 Nov 2026or earlierSales Representative - ClevelandSales & business developmentUS-OH-Cleveland
21 Nov 2026or earlierAuditor, Quality AssuranceFinance & accountingUS-MA-Burlington
21 Nov 2026or earlierSales Representative - ElizabethSales & business developmentUS-NJ-Elizabeth
21 Nov 2026or earlierDirector, Investor RelationsFinance & accountingUS-MA-Burlington
21 Nov 2026or earlierSales Representative - TampaSales & business developmentUS-FL-Tampa
21 Nov 2026or earlierSales Representative - SeattleSales & business developmentUS-Seattle
21 Nov 2026or earlierSr. Engineer, Post Market SurveillanceSoftware engineeringUS-MA-Burlington
21 Nov 2026or earlierSales Representative - BurbankSales & business developmentUS-CA-Burbank

The 5 newest of 78 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 27 Oct 2026Short interest and volume change

    had 1.8M shares sold short in the 15 Oct 2026 report, 1.5× the same report last year.

    Same report last year: 1.2M; its normal report is 1.2M.

    See the evidence
    This period
    1.8M (the 15 Oct 2026 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    73K
    How far from its usual level
    +4.5
    Same report last year
    1.2M
    History used
    3,212 days
    2025-10-15: 1.2M2025-10-31: 1.2M2025-11-14: 1.2M2025-11-28: 1.1M2025-12-15: 1.1M2025-12-31: 1.2M2026-01-15: 1.2M2026-01-30: 1.2M2026-02-13: 1.2M2026-02-27: 1.2M2026-03-13: 1.3M2026-03-31: 1.3M2026-04-15: 1.4M2026-04-30: 1.2M2026-05-15: 1.2M2026-05-29: 1.2M2026-06-15: 1.3M2026-06-30: 1.4M2026-07-15: 1.5M2026-07-31: 1.4M2026-08-14: 1.6M2026-08-31: 1.5M2026-09-15: 1.7M2026-09-30: 1.7M2026-10-15: 1.8M
    the 15 Oct 2026 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 15 Oct 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 15 Oct 2026Filings record

    Director or officer change

  4. 10 Oct 2026Short interest and volume change

    had 1.7M shares sold short in the 30 Sep 2026 report, 1.4× the same report last year.

    Same report last year: 1.2M; its normal report is 1.2M.

    See the evidence
    This period
    1.7M (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    69K
    How far from its usual level
    +4.2
    Same report last year
    1.2M
    History used
    3,197 days
    2025-09-30: 1.2M2025-10-15: 1.2M2025-10-31: 1.2M2025-11-14: 1.2M2025-11-28: 1.1M2025-12-15: 1.1M2025-12-31: 1.2M2026-01-15: 1.2M2026-01-30: 1.2M2026-02-13: 1.2M2026-02-27: 1.2M2026-03-13: 1.3M2026-03-31: 1.3M2026-04-15: 1.4M2026-04-30: 1.2M2026-05-15: 1.2M2026-05-29: 1.2M2026-06-15: 1.3M2026-06-30: 1.4M2026-07-15: 1.5M2026-07-31: 1.4M2026-08-14: 1.6M2026-08-31: 1.5M2026-09-15: 1.7M2026-09-30: 1.7M
    the 30 Sep 2026 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 25 Sep 2026Short interest and volume change

    had 1.7M shares sold short in the 15 Sep 2026 report, 1.3× the same report last year.

    Same report last year: 1.3M; its normal report is 1.2M.

    See the evidence
    This period
    1.7M (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    64K
    How far from its usual level
    +3.8
    Same report last year
    1.3M
    History used
    3,182 days
    2025-09-15: 1.3M2025-09-30: 1.2M2025-10-15: 1.2M2025-10-31: 1.2M2025-11-14: 1.2M2025-11-28: 1.1M2025-12-15: 1.1M2025-12-31: 1.2M2026-01-15: 1.2M2026-01-30: 1.2M2026-02-13: 1.2M2026-02-27: 1.2M2026-03-13: 1.3M2026-03-31: 1.3M2026-04-15: 1.4M2026-04-30: 1.2M2026-05-15: 1.2M2026-05-29: 1.2M2026-06-15: 1.3M2026-06-30: 1.4M2026-07-15: 1.5M2026-07-31: 1.4M2026-08-14: 1.6M2026-08-31: 1.5M2026-09-15: 1.7M
    the 15 Sep 2026 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 14 Apr 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 14 Apr 2026Filings record

    Director or officer change

  8. 14 Nov 2025Institutional holdings change

    saw 37 13F filers open a new position in the quarter ended 30 Sep 2025, 1.0× the same quarter last year.

    Same quarter last year: 37; its normal quarter is 24.

    See the evidence
    This period
    37 (the quarter ended 30 Sep 2025)
    Normal quarter (median of 8 earlier)
    24
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +3.5
    Same quarter last year
    37
    History used
    4,383 days
    2023-09-30: 242023-12-31: 202024-03-31: 352024-06-30: 342024-09-30: 372024-12-31: 242025-03-31: 232025-06-30: 242025-09-30: 37
    the quarter ended 30 Sep 20258 earlier quartersnormal: 24

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  9. 13 Feb 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 13 Feb 2025Filings record

    Director or officer change

  11. 12 Feb 2025Short interest and volume change

    had 1.3M shares sold short in the 31 Jan 2025 report, 1.4× the same report last year.

    Same report last year: 920K; its normal report is 854K.

    See the evidence
    This period
    1.3M (the 31 Jan 2025 report)
    Normal report (median of 24 earlier)
    854K
    Typical spread (median absolute deviation)
    76K
    How far from its usual level
    +4.0
    Same report last year
    920K
    History used
    2,590 days
    2024-01-31: 920K2024-02-15: 879K2024-02-29: 729K2024-03-15: 780K2024-03-28: 775K2024-04-15: 852K2024-04-30: 879K2024-05-15: 856K2024-05-31: 737K2024-06-14: 741K2024-06-28: 799K2024-07-15: 798K2024-07-31: 841K2024-08-15: 1.1M2024-08-30: 1.0M2024-09-13: 1.0M2024-09-30: 1.2M2024-10-15: 1.2M2024-10-31: 784K2024-11-15: 756K2024-11-29: 842K2024-12-13: 880K2024-12-31: 1.2M2025-01-15: 1.3M2025-01-31: 1.3M
    the 31 Jan 2025 report24 earlier reportsnormal: 854K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 28 Jan 2025Short interest and volume change

    had 1.3M shares sold short in the 15 Jan 2025 report, 1.3× the same report last year.

    Same report last year: 971K; its normal report is 854K.

    See the evidence
    This period
    1.3M (the 15 Jan 2025 report)
    Normal report (median of 24 earlier)
    854K
    Typical spread (median absolute deviation)
    76K
    How far from its usual level
    +3.9
    Same report last year
    971K
    History used
    2,574 days
    2024-01-12: 971K2024-01-31: 920K2024-02-15: 879K2024-02-29: 729K2024-03-15: 780K2024-03-28: 775K2024-04-15: 852K2024-04-30: 879K2024-05-15: 856K2024-05-31: 737K2024-06-14: 741K2024-06-28: 799K2024-07-15: 798K2024-07-31: 841K2024-08-15: 1.1M2024-08-30: 1.0M2024-09-13: 1.0M2024-09-30: 1.2M2024-10-15: 1.2M2024-10-31: 784K2024-11-15: 756K2024-11-29: 842K2024-12-13: 880K2024-12-31: 1.2M2025-01-15: 1.3M
    the 15 Jan 2025 report24 earlier reportsnormal: 854K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 26 Aug 2024Filings record

    Director or officer change

  14. 3 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 3 Jun 2024Filings record

    Director or officer change

  16. 15 May 2024Institutional holdings change

    saw 35 13F filers open a new position in the quarter ended 31 Mar 2024, 2.7× the same quarter last year.

    Same quarter last year: 13; its normal quarter is 21.5.

    See the evidence
    This period
    35 (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    21.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +3.6
    Same quarter last year
    13
    History used
    3,835 days
    2022-03-31: 242022-06-30: 212022-09-30: 222022-12-31: 142023-03-31: 132023-06-30: 412023-09-30: 242023-12-31: 202024-03-31: 35
    the quarter ended 31 Mar 20248 earlier quartersnormal: 21.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  17. 10 Feb 2024Short interest and volume change

    had 920K shares sold short in the 31 Jan 2024 report, 2.0× the same report last year.

    Same report last year: 455K; its normal report is 612K.

    See the evidence
    This period
    920K (the 31 Jan 2024 report)
    Normal report (median of 24 earlier)
    612K
    Typical spread (median absolute deviation)
    55K
    How far from its usual level
    +3.8
    Same report last year
    455K
    History used
    2,224 days
    2023-01-31: 455K2023-02-15: 512K2023-02-28: 608K2023-03-15: 616K2023-03-31: 576K2023-04-14: 610K2023-04-28: 607K2023-05-15: 539K2023-05-31: 528K2023-06-15: 616K2023-06-30: 608K2023-07-14: 614K2023-07-31: 579K2023-08-15: 593K2023-08-31: 575K2023-09-15: 620K2023-09-29: 733K2023-10-13: 932K2023-10-31: 1.2M2023-11-15: 1.1M2023-11-30: 952K2023-12-15: 949K2023-12-29: 961K2024-01-12: 971K2024-01-31: 920K
    the 31 Jan 2024 report24 earlier reportsnormal: 612K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 25 Jan 2024Short interest and volume change

    had 971K shares sold short in the 12 Jan 2024 report, 1.8× the same report last year.

    Same report last year: 551K; its normal report is 609K.

    See the evidence
    This period
    971K (the 12 Jan 2024 report)
    Normal report (median of 24 earlier)
    609K
    Typical spread (median absolute deviation)
    46K
    How far from its usual level
    +5.3
    Same report last year
    551K
    History used
    2,205 days
    2023-01-13: 551K2023-01-31: 455K2023-02-15: 512K2023-02-28: 608K2023-03-15: 616K2023-03-31: 576K2023-04-14: 610K2023-04-28: 607K2023-05-15: 539K2023-05-31: 528K2023-06-15: 616K2023-06-30: 608K2023-07-14: 614K2023-07-31: 579K2023-08-15: 593K2023-08-31: 575K2023-09-15: 620K2023-09-29: 733K2023-10-13: 932K2023-10-31: 1.2M2023-11-15: 1.1M2023-11-30: 952K2023-12-15: 949K2023-12-29: 961K2024-01-12: 971K
    the 12 Jan 2024 report24 earlier reportsnormal: 609K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 11 Jan 2024Short interest and volume change

    had 961K shares sold short in the 29 Dec 2023 report, 1.7× the same report last year.

    Same report last year: 581K; its normal report is 608K.

    See the evidence
    This period
    961K (the 29 Dec 2023 report)
    Normal report (median of 24 earlier)
    608K
    Typical spread (median absolute deviation)
    32K
    How far from its usual level
    +5.8
    Same report last year
    581K
    History used
    2,191 days
    2022-12-30: 581K2023-01-13: 551K2023-01-31: 455K2023-02-15: 512K2023-02-28: 608K2023-03-15: 616K2023-03-31: 576K2023-04-14: 610K2023-04-28: 607K2023-05-15: 539K2023-05-31: 528K2023-06-15: 616K2023-06-30: 608K2023-07-14: 614K2023-07-31: 579K2023-08-15: 593K2023-08-31: 575K2023-09-15: 620K2023-09-29: 733K2023-10-13: 932K2023-10-31: 1.2M2023-11-15: 1.1M2023-11-30: 952K2023-12-15: 949K2023-12-29: 961K
    the 29 Dec 2023 report24 earlier reportsnormal: 608K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 28 Dec 2023Short interest and volume change

    had 949K shares sold short in the 15 Dec 2023 report, 1.7× the same report last year.

    Same report last year: 557K; its normal report is 608K.

    See the evidence
    This period
    949K (the 15 Dec 2023 report)
    Normal report (median of 24 earlier)
    608K
    Typical spread (median absolute deviation)
    32K
    How far from its usual level
    +5.6
    Same report last year
    557K
    History used
    2,177 days
    2022-12-15: 557K2022-12-30: 581K2023-01-13: 551K2023-01-31: 455K2023-02-15: 512K2023-02-28: 608K2023-03-15: 616K2023-03-31: 576K2023-04-14: 610K2023-04-28: 607K2023-05-15: 539K2023-05-31: 528K2023-06-15: 616K2023-06-30: 608K2023-07-14: 614K2023-07-31: 579K2023-08-15: 593K2023-08-31: 575K2023-09-15: 620K2023-09-29: 733K2023-10-13: 932K2023-10-31: 1.2M2023-11-15: 1.1M2023-11-30: 952K2023-12-15: 949K
    the 15 Dec 2023 report24 earlier reportsnormal: 608K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 12 Dec 2023Short interest and volume change

    had 952K shares sold short in the 30 Nov 2023 report, 1.7× the same report last year.

    Same report last year: 568K; its normal report is 600K.

    See the evidence
    This period
    952K (the 30 Nov 2023 report)
    Normal report (median of 24 earlier)
    600K
    Typical spread (median absolute deviation)
    24K
    How far from its usual level
    +5.9
    Same report last year
    568K
    History used
    2,162 days
    2022-11-30: 568K2022-12-15: 557K2022-12-30: 581K2023-01-13: 551K2023-01-31: 455K2023-02-15: 512K2023-02-28: 608K2023-03-15: 616K2023-03-31: 576K2023-04-14: 610K2023-04-28: 607K2023-05-15: 539K2023-05-31: 528K2023-06-15: 616K2023-06-30: 608K2023-07-14: 614K2023-07-31: 579K2023-08-15: 593K2023-08-31: 575K2023-09-15: 620K2023-09-29: 733K2023-10-13: 932K2023-10-31: 1.2M2023-11-15: 1.1M2023-11-30: 952K
    the 30 Nov 2023 report24 earlier reportsnormal: 600K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 28 Nov 2023Short interest and volume change

    had 1.1M shares sold short in the 15 Nov 2023 report, 1.9× the same report last year.

    Same report last year: 547K; its normal report is 587K.

    See the evidence
    This period
    1.1M (the 15 Nov 2023 report)
    Normal report (median of 24 earlier)
    587K
    Typical spread (median absolute deviation)
    29K
    How far from its usual level
    +8.1
    Same report last year
    547K
    History used
    2,147 days
    2022-11-15: 547K2022-11-30: 568K2022-12-15: 557K2022-12-30: 581K2023-01-13: 551K2023-01-31: 455K2023-02-15: 512K2023-02-28: 608K2023-03-15: 616K2023-03-31: 576K2023-04-14: 610K2023-04-28: 607K2023-05-15: 539K2023-05-31: 528K2023-06-15: 616K2023-06-30: 608K2023-07-14: 614K2023-07-31: 579K2023-08-15: 593K2023-08-31: 575K2023-09-15: 620K2023-09-29: 733K2023-10-13: 932K2023-10-31: 1.2M2023-11-15: 1.1M
    the 15 Nov 2023 report24 earlier reportsnormal: 587K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 10 Nov 2023Short interest and volume change

    had 1.2M shares sold short in the 31 Oct 2023 report, 1.5× the same report last year.

    Same report last year: 806K; its normal report is 587K.

    See the evidence
    This period
    1.2M (the 31 Oct 2023 report)
    Normal report (median of 24 earlier)
    587K
    Typical spread (median absolute deviation)
    29K
    How far from its usual level
    +10.4
    Same report last year
    806K
    History used
    2,132 days
    2022-10-31: 806K2022-11-15: 547K2022-11-30: 568K2022-12-15: 557K2022-12-30: 581K2023-01-13: 551K2023-01-31: 455K2023-02-15: 512K2023-02-28: 608K2023-03-15: 616K2023-03-31: 576K2023-04-14: 610K2023-04-28: 607K2023-05-15: 539K2023-05-31: 528K2023-06-15: 616K2023-06-30: 608K2023-07-14: 614K2023-07-31: 579K2023-08-15: 593K2023-08-31: 575K2023-09-15: 620K2023-09-29: 733K2023-10-13: 932K2023-10-31: 1.2M
    the 31 Oct 2023 report24 earlier reportsnormal: 587K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 25 Oct 2023Short interest and volume change

    had 932K shares sold short in the 13 Oct 2023 report, 1.1× the same report last year.

    Same report last year: 811K; its normal report is 587K.

    See the evidence
    This period
    932K (the 13 Oct 2023 report)
    Normal report (median of 24 earlier)
    587K
    Typical spread (median absolute deviation)
    29K
    How far from its usual level
    +5.9
    Same report last year
    811K
    History used
    2,114 days
    2022-10-14: 811K2022-10-31: 806K2022-11-15: 547K2022-11-30: 568K2022-12-15: 557K2022-12-30: 581K2023-01-13: 551K2023-01-31: 455K2023-02-15: 512K2023-02-28: 608K2023-03-15: 616K2023-03-31: 576K2023-04-14: 610K2023-04-28: 607K2023-05-15: 539K2023-05-31: 528K2023-06-15: 616K2023-06-30: 608K2023-07-14: 614K2023-07-31: 579K2023-08-15: 593K2023-08-31: 575K2023-09-15: 620K2023-09-29: 733K2023-10-13: 932K
    the 13 Oct 2023 report24 earlier reportsnormal: 587K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 14 Aug 2023Institutional holdings change

    saw 41 13F filers open a new position in the quarter ended 30 Jun 2023, 2.0× the same quarter last year.

    Same quarter last year: 21; its normal quarter is 21.

    See the evidence
    This period
    41 (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    21
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +4.5
    Same quarter last year
    21
    History used
    3,560 days
    2021-06-30: 212021-09-30: 242021-12-31: 102022-03-31: 242022-06-30: 212022-09-30: 222022-12-31: 142023-03-31: 132023-06-30: 41
    the quarter ended 30 Jun 20238 earlier quartersnormal: 21

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  26. 23 Sep 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 23 Sep 2022Filings record

    Director or officer change

  28. 28 Apr 2022Filings record

    Restructuring costs announced

  29. 29 Mar 2022Insiders record

    Roush John A (director) bought 30 shares of LMAT ($932) (dated 28 Mar 2022)

  30. 29 Mar 2022Insiders record

    Roush John A (director) bought 151 shares of LMAT ($3,817) (dated 28 Mar 2022)

  31. 2 Dec 2021Filings record

    A major agreement ended

  32. 9 Jul 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 9 Jul 2021Filings record

    Director or officer change

  34. 16 Feb 2021Institutional holdings change

    saw 37 13F filers open a new position in the quarter ended 31 Dec 2020, 1.4× the same quarter last year.

    Same quarter last year: 26; its normal quarter is 14.5.

    See the evidence
    This period
    37 (the quarter ended 31 Dec 2020)
    Normal quarter (median of 8 earlier)
    14.5
    Typical spread (median absolute deviation)
    2.5
    How far from its usual level
    +6.1
    Same quarter last year
    26
    History used
    2,649 days
    2018-12-31: 122019-03-31: 292019-06-30: 162019-09-30: 132019-12-31: 262020-03-31: 122020-06-30: 162020-09-30: 112020-12-31: 37
    the quarter ended 31 Dec 20208 earlier quartersnormal: 14.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  35. 18 Aug 2020Insiders record

    Roberts David B (President and Director) bought 7,074 shares of LMAT ($200,548) (dated 17 Aug 2020)

  36. 30 Apr 2020Filings record

    Director or officer change

  37. 17 Apr 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 17 Apr 2020Filings record

    Director or officer change

  39. 17 Apr 2020Filings record

    Restructuring costs announced

  40. 17 Oct 2019Filings record

    Completed an acquisition or asset sale

Showing the newest 40 of 45 entries; narrow the window or the kind of data to see older ones.

Not listed: 299 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001158895
Ticker
LMAT
Domain
lemaitre.com
Employer name
LeMaitre Vascular, Inc. (1 unverified)
Hq location
MA|BURLINGTON|01803 (1 unverified)
Name
Bio Nova Holdings Pty Ltd, Bio Nova International Pty Ltd, LeMaitre Acquisition LLC, LeMaitre Cardial SAS and 9 more
Uei
JWGPQCB8NFQ5
Wikipedia
LeMaitre Vascular
  • DOL H-1B labor condition applications and PERM certifications46 data points13 Jan 2020 to 5 May 2025
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)129 records24 Feb 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1126 data points31 Dec 2008 to 2 Nov 2026
  • SEC Form 4 insider transactions191 records, 616 data points12 Jan 2016 to 11 May 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards1362 data points1 Oct 2007 to 20 Nov 2026
  • Wikipedia pageviews10 data points11 Nov 2026 to 20 Nov 2026